Different impacts of TP53 mutations on cell cycle-related gene expression among cancer types

por Sasaki, Keiju, Takahashi, Shin, Ouchi, Kota, Otsuki, Yasufumi, Wakayama, Shonosuke, Ishioka, Chikashi
Publicado 2023

Altered gene expression due to aberrant DNA methylation correlates with responsiveness to anti‐EGFR antibody treatment

por Otsuki, Yasufumi, Ouchi, Kota, Takahashi, Shin, Sasaki, Keiju, Sakamoto, Yasuhiro, Okita, Akira, Ishioka, Chikashi
Publicado 2022

Consensus molecular subtypes classification of colorectal cancer as a predictive factor for chemotherapeutic efficacy against metastatic colorectal cancer

por Okita, Akira, Takahashi, Shin, Ouchi, Kota, Inoue, Masahiro, Watanabe, Mika, Endo, Mareyuki, Honda, Hiroshi, Yamada, Yasuhide, Ishioka, Chikashi
Publicado 2018

microRNA-193a-3p is specifically down-regulated and acts as a tumor suppressor in BRAF-mutated colorectal cancer

por Takahashi, Hidekazu, Takahashi, Masanobu, Ohnuma, Shinobu, Unno, Michiaki, Yoshino, Yuki, Ouchi, Kota, Takahashi, Shin, Yamada, Yasuhide, Shimodaira, Hideki, Ishioka, Chikashi
Publicado 2017

A modified MethyLight assay predicts the clinical outcomes of anti‐epidermal growth factor receptor treatment in metastatic colorectal cancer

por Ouchi, Kota, Takahashi, Shin, Okita, Akira, Sakamoto, Yasuhiro, Muto, Osamu, Amagai, Kenji, Okada, Takaho, Ohori, Hisatsugu, Shinozaki, Eiji, Ishioka, Chikashi
Publicado 2022

DNA methylation status as a biomarker of anti‐epidermal growth factor receptor treatment for metastatic colorectal cancer

por Ouchi, Kota, Takahashi, Shin, Yamada, Yasuhide, Tsuji, Shingo, Tatsuno, Kenji, Takahashi, Hidekazu, Takahashi, Naoki, Takahashi, Masanobu, Shimodaira, Hideki, Aburatani, Hiroyuki, Ishioka, Chikashi
Publicado 2015

Efficacy of modified FOLFOX6 chemotherapy for patients with unresectable pseudomyxoma peritonei

por Hiraide, Sakura, Komine, Keigo, Sato, Yuko, Ouchi, Kota, Imai, Hiroo, Saijo, Ken, Takahashi, Masahiro, Takahashi, Shin, Shirota, Hidekazu, Takahashi, Masanobu, Ishioka, Chikashi
Publicado 2019

BRAF and MEK Inhibitor Treatment for Metastatic Undifferentiated Sarcoma of the Spermatic Cord with BRAF V600E Mutation

por Saijo, Ken, Imai, Hiroo, Katayama, Hiromichi, Fujishima, Fumiyoshi, Nakamura, Kenichi, Kasahara, Yuki, Ouchi, Kota, Komine, Keigo, Shirota, Hidekazu, Takahashi, Masanobu, Ishioka, Chikashi
Publicado 2022

Depth of response may predict clinical outcome in patients with recurrent/metastatic head and neck cancer treated with pembrolizumab-containing regimens

por Saijo, Ken, Imai, Hiroo, Ouchi, Kota, Sasaki, Keiju, Yoshida, Yuya, Kawamura, Yoshifumi, Taniguchi, Sakura, Kasahara, Yuki, Komine, Keigo, Shirota, Hidekazu, Takahashi, Masanobu, Ishioka, Chikashi
Publicado 2023

Antibiotics Improve the Treatment Efficacy of Oxaliplatin-Based but Not Irinotecan-Based Therapy in Advanced Colorectal Cancer Patients

por Imai, Hiroo, Saijo, Ken, Komine, Keigo, Yoshida, Yuya, Sasaki, Keiju, Suzuki, Asako, Ouchi, Kota, Takahashi, Masahiro, Takahashi, Shin, Shirota, Hidekazu, Takahashi, Masanobu, Ishioka, Chikashi
Publicado 2020

Multicentre single-arm phase II trial evaluating the safety and effiCacy of Panitumumab and iRinOtecan in NeoRAS Wild-type mEtaStatic colorectal cancer patientS (C-PROWESS trial):...

por Osumi, Hiroki, Ishizuka, Naoki, Takashima, Atsuo, Kumekawa, Yosuke, Nakano, Daisuke, Shiozawa, Manabu, Denda, Tadamichi, Sawada, Ryoichi, Ouchi, Kota, Wakatsuki, Takeru, Narikazu, Boku, Kato, Ken, Yamaguchi, Kensei, Shinozaki, Eiji
Publicado 2022

Inhibition of stearoyl-CoA desaturase 1 (SCD1) enhances the antitumor T cell response through regulating β-catenin signaling in cancer cells and ER stress in T cells and synergizes...

por Katoh, Yuki, Yaguchi, Tomonori, Kubo, Akiko, Iwata, Takashi, Morii, Kenji, Kato, Daiki, Ohta, Shigeki, Satomi, Ryosuke, Yamamoto, Yasuhiro, Oyamada, Yoshitaka, Ouchi, Kota, Takahashi, Shin, Ishioka, Chikashi, Matoba, Ryo, Suematsu, Makoto, Kawakami, Yutaka
Publicado 2022

The G8 screening tool enhances prognostic value to ECOG performance status in elderly cancer patients: A retrospective, single institutional study

por Takahashi, Masahiro, Takahashi, Masanobu, Komine, Keigo, Yamada, Hideharu, Kasahara, Yuki, Chikamatsu, Sonoko, Okita, Akira, Ito, Shukuei, Ouchi, Kota, Okada, Yoshinari, Imai, Hiroo, Saijo, Ken, Shirota, Hidekazu, Takahashi, Shin, Mori, Takahiro, Shimodaira, Hideki, Ishioka, Chikashi
Publicado 2017

Retrospective analysis on the clinical outcomes of recombinant human soluble thrombomodulin for disseminated intravascular coagulation syndrome associated with solid tumors

por Ouchi, Kota, Takahashi, Shin, Chikamatsu, Sonoko, Ito, Shukuei, Takahashi, Yoshikazu, Kawai, Sadayuki, Okita, Akira, Kasahara, Yuki, Okada, Yoshinari, Imai, Hiroo, Komine, Keigo, Saijo, Ken, Takahashi, Masahiro, Shirota, Hidekazu, Takahashi, Masanobu, Gamoh, Makio, Ishioka, Chikashi
Publicado 2018

A multi-institutional observational study evaluating the incidence and the clinicopathological characteristics of NeoRAS wild-type metastatic colorectal cancer

por Osumi, Hiroki, Takashima, Atsuo, Ooki, Akira, Yoshinari, Yuri, Wakatsuki, Takeru, Hirano, Hidekazu, Nakayama, Izuma, Okita, Natsuko, Sawada, Ryoichi, Ouchi, Kota, Fukuda, Koshiro, Fukuoka, Shota, Ogura, Mariko, Takahari, Daisuke, Chin, Keisho, Shoji, Hirokazu, Kato, Ken, Ishizuka, Naoki, Boku, Narikazu, Yamaguchi, Kensei, Shinozaki, Eiji
Publicado 2023

Phase II study of trifluridine/tipiracil (TAS-102) therapy in elderly patients with colorectal cancer (T-CORE1401): geriatric assessment tools and plasma drug concentrations as pos...

por Takahashi, Masanobu, Sakamoto, Yasuhiro, Ohori, Hisatsugu, Tsuji, Yasushi, Kuroki, Michio, Kato, Satoshi, Otsuka, Kazunori, Komine, Keigo, Takahashi, Masahiro, Takahashi, Shin, Shirota, Hidekazu, Ouchi, Kota, Takahashi, Yoshikazu, Imai, Hiroo, Shibata, Hiroyuki, Yoshioka, Takashi, Tanaka, Masaki, Yamaguchi, Hiroaki, Yamaguchi, Takuhiro, Shimodaira, Hideki, Ishioka, Chikashi
Publicado 2021

Advanced colorectal cancer subtypes (aCRCS) help select oxaliplatin‐based or irinotecan‐based therapy for colorectal cancer

por Takahashi, Shin, Sakamoto, Yasuhiro, Denda, Tadamichi, Takashima, Atsuo, Komatsu, Yoshito, Nakamura, Masato, Ohori, Hisatsugu, Yamaguchi, Tatsuro, Kobayashi, Yoshimitsu, Baba, Hideo, Kotake, Masanori, Amagai, Kenji, Kondo, Hitoshi, Shimada, Ken, Sato, Atsushi, Yuki, Satoshi, Okita, Akira, Ouchi, Kota, Komine, Keigo, Watanabe, Mika, Morita, Satoshi, Ishioka, Chikashi
Publicado 2021

Prevalence of opioid-induced adverse events across opioids commonly used for analgesic treatment in Japan: a multicenter prospective longitudinal study

por Hiratsuka, Yusuke, Tagami, Keita, Inoue, Akira, Sato, Mamiko, Matsuda, Yasufumi, Kosugi, Kazuhiro, Kubo, Emi, Natsume, Maika, Ishiki, Hiroto, Arakawa, Sayaka, Shimizu, Masaki, Yokomichi, Naosuke, Chiu, Shih-Wei, Shimoda, Mayu, Hirayama, Hideyuki, Nishijima, Kaoru, Ouchi, Kota, Shimoi, Tatsunori, Shigeno, Tomoko, Yamaguchi, Takuhiro, Miyashita, Mitsunori, Morita, Tatsuya, Satomi, Eriko
Publicado 2023

Phase II study of biweekly cetuximab plus mFOLFOX6 or mFOLFIRI as second-line treatment for metastatic colorectal cancer and exploratory analysis of associations between DNA methyl...

por Takahashi, Shin, Ouchi, Kota, Sakamoto, Yasuhiro, Mori, Takahiro, Shimodaira, Hideki, Takahashi, Masahiro, Ohori, Hisatsugu, Kudo, Chieko, Takahashi, Yoshikazu, Imai, Hiroo, Akiyama, Shoko, Takahashi, Masanobu, Suto, Takeshi, Murakawa, Yasuko, Oishi, Takayuki, Isobe, Hideki, Okada, Yoshinari, Kawai, Sadayuki, Yoshioka, Takashi, Sato, Toshihiko, Shindo, Yoshiaki, Sugiyama, Shunsuke, Komine, Keigo, Chiba, Natsuko, Okita, Akira, Yamaguchi, Takuhiro, Ishioka, Chikashi
Publicado 2023